Multiple Sclerosis Clinical Trial
Official title:
Effect Aquatic Exercise Training on Patients With Multiple Sclerosis
NCT number | NCT02882724 |
Other study ID # | 201527921IR |
Secondary ID | |
Status | Completed |
Phase | Phase 1 |
First received | August 15, 2016 |
Last updated | August 29, 2016 |
Start date | January 2016 |
Verified date | August 2016 |
Source | University of Isfahan |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ethics Committee |
Study type | Interventional |
Background: It has been shown that adults with Multiple sclerosis (MS) have less leg
strength than their peers, as well as impaired balance, which has led to an increased
prevalence of falls in this population.The purpose of this study was to assess the effects
of 8-weeks aquatic exercise training in balance, endurance and speed in women with MS.
Methods: In this semi-experimental study, 32 women with clinically-definite
relapsing-remittent MS who were registered through the Isfahan MS association volunteered
for this study. They randomly selected an aquatic exercise (n = 17) and control (n = 15)
groups. Aquatic exercise group completed a 8-week aquatic exercise training program
consisted of three sessions per week, each session lasting 45 to 60 minutes 50 to 75 percent
of their maximum heart rate reserve on 20-25 degree centigrade's, whereas the control group
was instructed to maintain their current lifestyle. The balance of angry was surveyed with
using of Berg analyze, speed and endurance 6 minutes walking test before starting of
exercise program and after 4 weeks and at the end of 8 weeks was analyzed. The obtained
data's were analyzed using analysis of variance with repeated measures.
Status | Completed |
Enrollment | 32 |
Est. completion date | |
Est. primary completion date | April 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 50 Years |
Eligibility |
Inclusion Criteria: - All women diagnosis of clinically or laboratory supported MS, a minimum time of two years since the diagnosis was made, no relapse within the 4 weeks preceding baseline, ability to participate in regular exercise sessions. Exclusion Criteria: - Patients were excluded from the study if they had a relapse during the intervention period, and had a disease preventing their participation (e.g. cardiovascular, respiratory or skeletal diseases). |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Isfahan |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effect of exercise on balance was surveyed with using of Berg analyze | up to 8 weeks | No | |
Secondary | Effect of exercise on speed was measured by walking test | Up to 8 weeks | No | |
Secondary | Effect of exercise on endurance was measured by walking test | Up to 8 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |